Can a simple blood test predict which pancreatic cysts turn cancerous?

NCT ID NCT06574373

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study is looking for biological markers in the blood and tissue that can tell apart harmless pancreatic cysts (IPMN) from those that are likely to turn into pancreatic cancer. Researchers will follow 3,600 patients with IPMN across four Italian hospitals, collecting blood samples and analyzing tissue from those who have surgery. The goal is to improve how doctors decide who needs surgery and who can be safely watched, reducing unnecessary procedures and catching cancer earlier.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could lead to better tests to identify which IPMN patients need surgery and which can be safely monitored, potentially preventing pancreatic cancer deaths.
What could go wrong
This is an observational study, not a treatment trial. It may not find reliable biomarkers, and any new tests would need further validation before changing patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IPMN, PANCREATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione Policlinico Gemelli

    RECRUITING

    Roma, 00168, Italy

  • IRCCS Fondazione Policlinico Universitario A. Gemelli

    NOT_YET_RECRUITING

    Rome, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.